Framing the Future: ZAS Group’s Visionary Roadmap for Success
ZAS Group recently hosted the event “Next Wave of ZAS Group – Framing the Future of ZAS,” uniting leaders from […]
International Business Team of ZAS Pharma Ltd Embarks on an Inspiring ‘Rise & Refresh 2025’ Tour.
The International Business Team of ZAS Pharma Ltd recently came together for an unforgettable experience during their Rise & Refresh
ZAS Onco Team Charts the Course with “Leap Into 2025”
The ZAS Onco Team commenced 2025 on a high note with their annual strategic and planning meeting titled “Leap Into
ZAS Critical Care Team Charts the Course with “Leap Into 2025”
The ZAS Critical Care Team commenced 2025 on a high note with their annual strategic and planning meeting titled “Leap
Round Table Discussion on Preventing Recurrent RTIs in Children
Our Baby Care team recently hosted an engaging and insightful Round Table discussion with leading pediatricians, focusing on the prevention
ZAS Group celebrates the New Year 2025 with its Champions.
As we enter 2025, we are filled with renewed energy and a shared vision for a brighter future. At ZAS,
ZAS Corporation Ltd. Signs MOU with The Ibn Sina Trust to Enhance Employee Healthcare Access
ZAS Corporation Ltd. is proud to announce the signing of a Memorandum of Understanding (MOU) with The Ibn Sina Trust,
Rise & Refresh: ZAS Corporation’s Inspiring Year-End Retreat to Kuakata
ZAS Corporation Headquarters team wrapped up 2024 with an unforgettable recreation tour to the picturesque beaches of Kuakata. Surrounded by
ZAS Corporation Ltd. Partners with LABAID Diagnostics and LABAID Cancer Hospital for Employee Healthcare
ZAS Corporation Ltd. is delighted to announce the signing of a Memorandum of Understanding (MOU) with LABAID Diagnostics and LABAID
ZAS Corporation Introduces Uro-Vaxom to Bangladesh: A Milestone in UTI Prevention
ZAS Corporation proudly launched Uro-Vaxom, an advanced immunotherapeutic solution by OM Pharma, Switzerland, for preventing recurrent urinary tract infections (UTIs).